Search
Advanced search

Company search

Company/VAT no/Free text Country/City/Municipality

TURNOVER (x1000 SEK)

NET PROFIT (x1000 SEK)

EMPLOYEES

Share

Xbrane Biopharma AB

Closing information (x1000 SEK)

Closing information 2023/12 (consolidated) 2022/12 (consolidated) 2021/12 (consolidated)
Turnover 238,729 Less Arrow 57,618 Less Arrow 0
Financial expenses 18,562 Less Arrow 2,296 More Arrow 2,643
Earnings before taxes -322,028 More Arrow -168,513 Less Arrow -183,226
EBITDA -300,758 More Arrow -158,776 Less Arrow -168,366
Total assets 653,508 More Arrow 690,515 Less Arrow 688,427
Current assets 461,693 More Arrow 513,524 More Arrow 561,008
Current liabilities 326,557 Less Arrow 236,569 Less Arrow 219,667
Equity capital 171,335 More Arrow 424,888 More Arrow 431,741
- share capital 6,683 Less Arrow 6,166 Less Arrow 5,614
Employees (average) 89 Less Arrow 68 Less Arrow 50

Financial ratios

Fiscal year 2023/12 (consolidated) 2022/12 (consolidated) 2021/12 (consolidated)
Solvency 26.2% More Arrow 61.5% More Arrow 62.7%
Turnover per employee 2,682 Less Arrow 847 Less Arrow 0
Profit as a percentage of turnover -134.9% Less Arrow -292.5%
Return on assets (ROA) -46.4% More Arrow -24.1% Less Arrow -26.2%
Current ratio 141.4% More Arrow 217.1% More Arrow 255.4%
Return on equity (ROE) -188.0% More Arrow -39.7% Less Arrow -42.4%
Change turnover 181,111 Less Arrow 57,618 Less Arrow 0
Change turnover % 314%
Chg. No. of employees 21 Less Arrow 18 Less Arrow 11
Chg. No. of employees % 31% More Arrow 36% Less Arrow 28%

Total value of public sale

Fiscal year 2023/12 (consolidated) 2022/12 (consolidated) 2021/12 (consolidated)
Total value of public sale 0 Equal arrow 0 Equal arrow 0

Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank

The closing information is gathered directly from the companies or from Creditsafe.